
News
Announcement
Following the integration of Omega Laboratories Ltd. and Juno Pharmaceuticals Corp. that became Juno Pharma Canada Inc., we have decided to do a complete strategic review of our different business units, including our Allergy Division. Juno is committed to continuing to invest in our Allergy Division in bringing new products to our portfolio and based on its long experience and company legacy, we are pleased to announce that we have decided to change the name of our Allergy Division from Viva Allergy to Omega Allergies.

CPHI 2024 - Milan
Read More
New Product Launch: Eptifibatide
Read More